Document is current
Any future updates will be listed below
-
Authors
Hu, Jing
Qiu, Ziqi
Xia, Daolin
Zhang, Wenwen
Fang, Zhaojing
Ling, Meirong
Ding, Mingxia
- License Information
-
More Information
Article History
Received: 14 September 2025
Accepted: 6 April 2026
First Online: 18 April 2026
Declarations
:
: This prospective, randomized controlled trial received approval from the institutional review board of Nanjing First Hospital (KY20230116-08) and was pre-registered in the Chinese Clinical Trial Registry (ChiCTR2300068412, principal investigator: J. Gu, MD, PhD, date of registration: 17/02/2023). The research was carried out strictly in compliance with the Declaration of Helsinki and Good Clinical Practice guidelines and followed the CONSORT guidelines. Written informed consent was obtained from all patients.
: Not applicable.
: The authors declare no competing interests.
